EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Examining Differences Among Opioid Agonist Treatment Clients in Regional and Metropolitan Settings of New South Wales, Australia

Daniel T Winter iD, Lauren A Monds iD, Nicholas Lintzeris iD, Paul S Haber iD, Carolyn A Day iD

Australian Journal of Rural Health · 2025

DOI: 10.1111/ajr.70029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian Journal of Rural Health, 2025. Verfasst von Daniel T Winter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, the University of Sydney, Sydney, New South Wales, Australi…. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Opiate Substitution Treatment, Analgesics, Opioid, Urban Population. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New South Wales Ministry of Health, NSW Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Whilst prior studies have examined characteristics and barriers for opioid agonist treatment (OAT) clients in regional settings, there are limited studies examining these differences in relation to metropolitan OAT clients. This study aimed to examine key characteristics, including sedating medication and substance use, transport and driving behaviours and differences between OAT clients within regional and metropolitan areas of New South Wales, Australia.

Design

Cross‐sectional survey of OAT clients.

Setting

Fifteen public OAT clinics across New South Wales, Australia, between January 2020 and June 2021.

Participants

Survey was completed by 482 people currently receiving OAT. Main Outcome Measures Self‐reported sample characteristics, self‐reported sedating medication use and substance use, transportation and driving histories.

Results

Significant differences in OAT pharmacotherapies prescribed between regional and metropolitan participants were noted (aOR = 2.42, 95% CI = 1.42–4.11). Methadone was the most commonly prescribed OAT in both settings (74.1% and 54.4%, respectively). Nearly half (45.6%) of regional participants received OAT from a private dispensary compared to 4.7% in metropolitan areas. While few differences in past‐month substance use were noted, reported heroin use was lower (aOR = 0.27; 95% CI = 0.09–0.78) in regional areas. Regional participants were more likely than metropolitan participants to drive a vehicle to dosing (aOR = 2.89, 95% CI = 1.12–7.46) and less likely to take public transport (aOR = 0.41, 95% CI = 0.18–0.93) or active transport (aOR = 3.75, 95% CI = 1.50–9.40). Few differences regarding driving offences, based on geography, were noted.

Conclusions

Key differences with treatment, substance use, transport and driving were noted within this study. It is evident that regional OAT clients more often rely on motor vehicles to complete daily activities. Such challenges related to OAT should be addressed by informed policy and regulatory changes that ensure access and equity of treatment and safety, regardless of location.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersOpiate Substitution TreatmentAnalgesics, OpioidUrban PopulationHumansNew South WalesCross-Sectional StudiesMaleFemaleAdultMiddle AgedSurveys and QuestionnairesMethadone

Stichwörter der Autor:innen

opioid agonist treatmentopioid use disorderregional healthsubstance usetransporttreatment access

Substanzen

Analgesics, OpioidMethadone

Autor:innen und Institutionen

  • Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, the University of Sydney, Sydney, New South Wales, Australia.
  • Edith Collins Centre (Translational Research Centre in Alcohol Drugs and Toxicology), Sydney Local Health District, Camperdown, New South Wales, Australia.
  • Drug and Alcohol Services, Northern Sydney Local Health District, Sydney, New South Wales, Australia.
  • NSW Drug and Alcohol Clinical Research and Improvement Network (DACRIN), Sydney, New South Wales, Australia.
  • Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, New South Wales, Australia.
  • Drug Health Services, Sydney Local Health District, Camperdown, New South Wales, Australia.

ORCID-Profile: Daniel T Winter, Lauren A Monds, Nicholas Lintzeris, Paul S Haber, Carolyn A Day

Förderung

  • New South Wales Ministry of Health
  • NSW Health

Zitieren

APA

Winter, D. T., Monds, L. A., Lintzeris, N., Haber, P. S., & Day, C. A. (2025). Examining Differences Among Opioid Agonist Treatment Clients in Regional and Metropolitan Settings of New South Wales, Australia. Australian Journal of Rural Health. https://doi.org/10.1111/ajr.70029

Vancouver

Winter DT, Monds LA, Lintzeris N, Haber PS, Day CA. Examining Differences Among Opioid Agonist Treatment Clients in Regional and Metropolitan Settings of New South Wales, Australia. Australian Journal of Rural Health. 2025. doi:10.1111/ajr.70029

BibTeX
@article{Winter2025,
  author = {Winter, Daniel T and Monds, Lauren A and Lintzeris, Nicholas and Haber, Paul S and Day, Carolyn A},
  title = {Examining Differences Among Opioid Agonist Treatment Clients in Regional and Metropolitan Settings of New South Wales, Australia},
  journal = {Australian Journal of Rural Health},
  year = {2025},
  doi = {10.1111/ajr.70029}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche